David A. Siegel Axogen, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Axogen, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 10,400 shares of AXGN stock, worth $173,264. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,400

Holding current value

$173,264

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.52 - $14.69 $78,208 - $152,776	10,400 New	10,400 $145,000
Q2 2023 Aug 14, 2023	BUY	$8.5 - $10.38 $238,000 - $290,640	28,000 New	28,000 $255,000
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $140,656 - $195,041	14,900 New	14,900 $148,000
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $62,211 - $89,000	-8,900 Reduced 27.81%	23,100 $189,000
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $108,900 - $160,500	-15,000 Reduced 31.91%	32,000 $254,000
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $144,320 - $262,400	16,400 Added 53.59%	47,000 $440,000
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $654,890 - $933,960	-43,000 Reduced 58.42%	30,600 $483,000
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $213,600 - $282,000	12,000 Added 19.48%	73,600 $1.59 Million
Q1 2021 May 17, 2021	BUY	$17.18 - $22.6 $173,518 - $228,260	10,100 Added 19.61%	61,600 $1.25 Million
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $147,200 - $229,888	12,800 Added 33.07%	51,500 $922,000
Q3 2020 Nov 16, 2020	SELL	$10.62 - $13.12 $498,077 - $615,328	-46,900 Reduced 54.79%	38,700 $450,000
Q2 2020 Aug 14, 2020	BUY	$7.35 - $10.81 $629,160 - $925,336	85,600 New	85,600 $791,000
Q1 2020 May 15, 2020	SELL	$8.38 - $17.34 $126,538 - $261,834	-15,100 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $906,698 - $1.51 Million	-81,100 Reduced 84.3%	15,100 $270,000
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $53,196 - $90,024	4,400 Added 4.79%	96,200 $1.2 Million
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $736,300 - $1.01 Million	-39,800 Reduced 30.24%	91,800 $1.82 Million
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $1.23 Million - $1.86 Million	84,200 Added 177.64%	131,600 $2.77 Million
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $75,196 - $168,300	4,400 Added 10.23%	47,400 $968,000
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $1.77 Million - $2.9 Million	-51,900 Reduced 54.69%	43,000 $1.59 Million
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $2.23 Million - $3.24 Million	-61,800 Reduced 39.44%	94,900 $4.77 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $980,880 - $1.62 Million	40,200 Added 34.51%	156,700 $5.72 Million
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $825,100 - $1.28 Million	44,600 Added 62.03%	116,500 $3.3 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $1.05 Million - $1.39 Million	71,900	71,900 $1.39 Million

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $704M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account